查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2052060

糖尿病照護設備：市場趨勢、競爭格局與市場預測（至2034年）

Diabetes Care Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

糖尿病護理設備市場：概述

  • 全球糖尿病護理設備市場規模預計將從 2025 年的 407.8176 億美元成長到 2034 年的 764.0407 億美元，展現出強勁且持續的成長勢頭。
  • 全球糖尿病護理設備市場預計在 2026 年至 2034 年的預測期內將以 7.26% 的年複合成長率成長。
  • 糖尿病照護設備市場的主要驅動力是全球糖尿病盛行率的不斷上升，而這又源自於肥胖率的增加、久坐的生活方式以及人口老化。人們對早期診斷和持續血糖監測（CGM）重要性的認知不斷提高，推動了CGM、胰島素幫浦和智慧胰島素筆等先進設備的普及。數位連接、人工智慧整合和穿戴式解決方案等技術進步進一步提升了患者的便利性和治療的準確性。此外，有利的報銷政策、不斷完善的醫療基礎設施以及對自我管理和居家照護日益重視，也促進了市場的持續成長。
  • 在糖尿病護理設備市場中營運的主要公司包括：貝克頓·迪金森公司、諾和諾德公司、Ypsomed Holding AG、Tandem Diabetes Care, Inc.、百康有限公司、禮來公司、Insulet Corporation、雅培公司、泰爾茂株式會社、CeQur、EOFLOW CO., LTD、賽諾德公司、美金敦公司、美國森氏公司、5,2016氏公司、5,5,506氏公司。 Inc.、Senseonics、WaveForm Technologies, Inc. 和 B. Braun Melsungen AG。
  • 北美地區糖尿病盛行率高、醫療基礎設施完善，且先進技術（如持續血糖監測系統和胰島素幫浦）應用廣泛，預計將成為糖尿病護理設備市場的主要驅動力。此外，該地區還受益於優惠的健保政策、高額的醫療費用支出以及主要廠商的強大影響力，這些因素進一步推動了創新和產品的快速普及。同時，人們對早期診斷和有效疾病管理的日益重視也持續推動該地區對糖尿病護理設備的需求。
  • 按產品類型分類，預計到 2025 年，血糖值監測設備細分市場將佔據最大的市場佔有率。

推動糖尿病護理設備市場成長的因素

  • 糖尿病及其相關風險因素的日益普遍，正推動著糖尿病照護設備需求的激增：糖尿病盛行率的不斷攀升，以及肥胖、缺乏運動、不健康的飲食習慣和人口老化等相關風險因素，顯著提升了糖尿病照護設備的需求。隨著全球糖尿病確診人數的持續成長，對有效血糖值監測和胰島素輸註解決方案的需求也日益迫切，以更好地控制病情並預防併發症。患者數量的激增直接促進了血糖值監測系統（CGM）和胰島素幫浦等設備的普及應用。
  • 意識提升和自我管理趨勢的增強正在加速糖尿病護理設備市場的擴張：患者對糖尿病管理和定期血糖監測重要性的認知不斷提高，顯著促進了糖尿病護理設備的普及。健康教育的改善、數位化健康宣傳活動以及線上資訊取得管道的增加，促使患者採取更積極主動的自我管理方式。因此，市場對血糖值儀、動態血糖監測系統（CGM）和智慧胰島素輸註解決方案等操作簡單的設備需求日益成長，這些設備能夠幫助患者更好地控制血糖、改善治療效果並減少併發症。
  • 領先企業活性化產品研發投入：領導企業活性化產品研發投入正在推動糖尿病護理設備市場的成長。各企業持續投資研發，推出先進技術，例如動態血糖監測系統 (CGM)、智慧胰島素筆、穿戴式胰島素幫浦和整合式數位健康平台。這些創新提高了精準度、便利性和即時數據追蹤能力，從而改善了患者的治療效果和使用者體驗。頻繁的新產品發布和技術進步正在增強企業的競爭優勢，並擴大其在全球市場的滲透率。

最新糖尿病護理設備市場：市場動態與趨勢

全球糖尿病照護設備市場正經歷顯著成長，其主要促進因素包括糖尿病盛行率的上升以及肥胖、久坐不動的生活方式、不健康的飲食習慣和人口老化等相關風險因素。此外，主要公司活性化產品研發力度也進一步推動了市場擴張。

根據國際糖尿病聯盟（IDF，2025年）提供的數據，全球約有5.9億人患有糖尿病，約佔成年人口（20-79歲）的11.1%，即每九人中就有一人患有糖尿病。此外，預計到2050年，每八名成年人中就有一人患有糖尿病，約8.53億人，增幅達46%。全球糖尿病患者人數的顯著成長正在推動整個糖尿病護理設備市場的成長，因為越來越多的患者需要持續監測和有效的疾病管理。由於肥胖、缺乏運動、不健康飲食和人口老化等因素，1型和第2型糖尿病患者人數不斷增加，導致需要血糖值，以維持最佳血糖值並降低併發症風險。

此外，科技進步正在改變產業格局，穿戴式裝置和自動胰島素輸注（AID）裝置正成為主流。胰島素幫浦和貼片幫浦能夠實現持續胰島素輸注，為使用者帶來更大的便利性和更隱密的使用體驗。該領域的主要進展之一是獲得監管部門的核准。例如，瑞士醫療設備製造商PharmaSens於2024年1月向美國食品藥物管理局（FDA）提交了其胰島素貼片幫浦系統「niia essential」的申請。該系統已於2023年11月獲得ISO 13485認證，此申請被視為以患者為中心的先進胰島素幫浦技術邁向更廣泛應用的重要一步。

由於上述因素，預計糖尿病護理設備市場整體將在預測期內持續成長。

另一方面，也存在一些限制市場成長的因素。在血糖儀和動態血糖監測系統等糖尿病護理設備中，測量誤差和技術故障會導致胰島素輸注不當。這會增加低血糖和高血糖的風險，進而對患者的健康造成嚴重後果。此類測量精度問題會削弱使用者對設備的信心，並對治療效果產生負面影響。此外，由於安全性和性能問題導致的產品召回增加會影響品牌聲譽、監管力度和消費者整體信心，進一步阻礙市場成長。這些因素是糖尿病護理設備市場的重要限制因素。

本報告考察了全球糖尿病護理設備市場，提供了概述、市場影響因素和機會分析、法律制度、市場規模趨勢和預測、按各個細分市場和地區/主要國家進行的詳細分析、競爭格局以及主要公司的概況。

目錄

第1章：糖尿病照護設備市場：報告概述

  • 調查範圍
  • 市場區隔
  • 市場預期

第2章：糖尿病護理設備市場：執行摘要

  • 市場概覽

第3章：糖尿病照護設備市場：關鍵因素分析

  • 市場促進因素
    • 糖尿病盛行率的上升以及相關風險因素的增加，導致對糖尿病治療設備的需求激增。
    • 由於意識提升和自我管理趨勢的日益成長，糖尿病護理設備市場正在擴大。
    • 主要公司產品開發活動增加
  • 市場限制與挑戰
    • 測量誤差或技術誤差會導致胰島素劑量不正確，可能引起低血糖或高血糖。
    • 產品回收數量增加
  • 市場機遇
    • 人工智慧與機器學習的融合

第4章：影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅影響分析

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章 糖尿病照護設備市場：波特五力分析

第7章 糖尿病照護設備市場：市場評估

  • 依產品類型
    • 血糖監測設備
    • 胰島素輸注裝置
    • 整合系統
  • 按監測類別
    • 自我監測
    • 持續監測
  • 依患者類型
    • 1型
    • 類型 2
    • 妊娠糖尿病
  • 最終用戶
    • 醫院和診所
    • 居家照護環境
    • 其他
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章：新創企業資金籌措與投資趨勢

第10章 糖尿病照護設備市場：公司與產品概況

  • Becton, Dickinson and Company
  • Novo Nordisk A/S
  • Ypsomed Holding AG
  • Tandem Diabetes Care, Inc.
  • Biocon Ltd.
  • Eli Lilly and Company
  • Insulet Corporation
  • Abbott
  • Terumo Corporation
  • CeQur
  • EOFLOW CO., LTD
  • Sanofi
  • Medtronic
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services, Inc.
  • Dexcom Inc.
  • ARKRAY, Inc.
  • Senseonics
  • WaveForm Technologies, Inc.
  • B. Braun Melsungen AG

第11章：KOL的觀點

第12章 專案方法

第13章：關於 DelveInsight

第14章 免責聲明與諮詢

Product Code: DIMDCL0823

Diabetes Care Devices Market Summary

  • The global diabetes care devices market is expected to increase from USD 40,781.76 million in 2025 to USD 76,404.07 million by 2034, reflecting strong and sustained growth.
  • The global diabetes care devices market is growing at a CAGR of 7.26% during the forecast period from 2026 to 2034.
  • The diabetes care devices market is primarily driven by the rising global prevalence of diabetes, fueled by increasing obesity rates, sedentary lifestyles, and aging populations. Growing awareness about early diagnosis and the importance of continuous glucose monitoring is boosting the adoption of advanced devices such as CGMs, insulin pumps, and smart insulin pens. Technological advancements, including digital connectivity, AI integration, and wearable solutions, are further enhancing patient convenience and treatment accuracy. Additionally, supportive reimbursement policies, expanding healthcare infrastructure, and increasing emphasis on self-management and home-based care are contributing to sustained market growth.
  • The leading companies operating in the diabetes care devices market include Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo Corporation, CeQur, EOFLOW CO., LTD, Sanofi, Medtronic, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, and others.
  • North America is expected to dominate the diabetes care devices market due to the high prevalence of diabetes, strong healthcare infrastructure, and widespread adoption of advanced technologies such as continuous glucose monitoring (CGM) systems and insulin pumps. The region also benefits from favorable reimbursement policies, high healthcare expenditure, and strong presence of leading market players, which further support innovation and rapid product adoption. Additionally, increasing awareness about early diagnosis and effective disease management continues to drive demand for diabetes care devices in the region.
  • In the product type segment of the diabetes care devices market, the blood glucose monitoring devices category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Diabetes Care Devices Market

  • Increasing prevalence of diabetes and associated risk factors leading to a surge in diabetes care devices: The increasing prevalence of diabetes and its associated risk factors, such as obesity, sedentary lifestyles, unhealthy diets, and aging populations, is significantly driving the demand for diabetes care devices. As the number of individuals diagnosed with diabetes continues to rise globally, there is a growing need for effective glucose monitoring and insulin delivery solutions to manage the condition and prevent complications. This surge in patient population directly contributes to increased adoption of devices such as glucose monitors, continuous glucose monitoring systems, and insulin pumps.
  • Rising patient awareness and self-management trends is escalating the market of diabetes care devices: Rising patient awareness about diabetes management and the importance of regular glucose monitoring is significantly accelerating the adoption of diabetes care devices. Increasing health education, digital health campaigns, and access to online information are encouraging patients to take a proactive approach toward self-management. As a result, there is growing demand for user-friendly devices such as blood glucose monitors, continuous glucose monitoring (CGM) systems, and smart insulin delivery solutions that enable better control, improved outcomes, and reduced complications.
  • Increase in product development activites among the key market players: An increase in product development activities among key market players is driving the growth of the diabetes care devices market. Companies are continuously investing in research and development to introduce advanced technologies such as continuous glucose monitoring (CGM) systems, smart insulin pens, wearable insulin pumps, and integrated digital health platforms. These innovations enhance accuracy, convenience, and real-time data tracking, improving patient outcomes and user experience. Frequent product launches and technological advancements also strengthen competitive positioning and expand market adoption globally.

Diabetes Care Devices Market Report Segmentation

This diabetes care devices market report offers a comprehensive overview of the global diabetes care devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Blood Glucose Monitoring Devices {Wearable and Non Wearable}, Insulin Delivery Devices {Insulin Syringes, Insulin Pens, Insulin Pumps, and Others} and Integrated Systems), Monitoring (Self-Monitoring and Continous Monitoring), Patient Type (Type 1, Type 2, and Gestational Diabetes), End-Users (Hospitals & Clinics, Homecare Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing Diabetes Care Devices market.

A diabetes care device is a medical device used to monitor and manage blood glucose levels in individuals with diabetes. These devices help patients and healthcare professionals track glucose levels, deliver insulin, and improve overall disease management. Common examples include blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pens, insulin syringes, and insulin pumps, all designed to support effective diabetes control and reduce the risk of complications.

The diabetes care devices market is primarily driven by the rising global prevalence of diabetes, which is largely influenced by increasing obesity rates, sedentary lifestyles, unhealthy dietary habits, and the growing aging population worldwide. As the number of people diagnosed with diabetes continues to expand, there is a stronger need for effective tools to monitor and manage blood glucose levels, leading to higher adoption of advanced diabetes care solutions. Growing awareness about the importance of early diagnosis, regular monitoring, and maintaining optimal glycemic control is further encouraging patients and healthcare providers to use continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens. In addition, rapid technological advancements such as digital connectivity, mobile app integration, cloud-based data sharing, artificial intelligence (AI)-enabled analytics, and wearable devices are significantly improving accuracy, convenience, and real-time monitoring capabilities. These innovations enhance patient engagement and support personalized treatment approaches. Supportive reimbursement policies, expanding healthcare infrastructure, increasing healthcare expenditure, and the shift toward home-based care and self-management practices are also playing a crucial role in driving market growth. Together, these factors are creating a strong and sustained demand for modern diabetes care devices across global markets.

What are the latest diabetes care devices market dynamics and trends?

The global diabetes care devices market is growing significantly, driven by the increasing prevalence of diabetes andassociated risk factors such as obesity, sedentary lifestyles, unhealthy diets, and aging populations. Additionally, the market is further escalated by the increasing product development activites among the key market players.

According to data provided by the International Diabetes Federation (2025), approximately, 590 million worldwide had diabetes that is around 11.1% or 1 in 9 of the adult population (20-79 years) was living with diabetes. The projections further estimated that by 2050, 1 in 8 adults, approximately 853 million, will be living with diabetes, an increase of 46%. The increasing number of diabetes cases worldwide is significantly boosting the overall diabetes care devices market, as more patients require continuous monitoring and effective disease management solutions. Rising prevalence of type 1 and type 2 diabetes, driven by factors such as obesity, sedentary lifestyles, unhealthy diets, and aging populations, is expanding the patient pool in need of glucose monitoring and insulin delivery devices. This growing demand is encouraging the adoption of blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pens, and insulin pumps to help maintain optimal blood sugar levels and reduce the risk of complications.

Furthermore, the technological advancements have also reshaped the industry, as the industry is experiencing a notable shift towards wearable and automated insulin delivery (AID) devices. Insulin pumps and patch pumps offer continuous insulin infusion, providing greater convenience and discretion for users. A key development in this space is the push for regulatory approvals. For instance, in January 2024, PharmaSens, a Swiss medical device company, submitted an FDA application for its 'niia essential' insulin patch pump system. This application, following its ISO 13485 certification in November 2023, is a significant step toward making advanced, patient-centric insulin pump technology more widely available.

Thus, the factors mentioned above are expected to boost the overall market of diabetes care devices during the forecast period.

However, False readings or technical errors in diabetes care devices, such as glucose meters and continuous glucose monitoring systems, can lead to incorrect insulin dosing, increasing the risk of hypoglycemia or hyperglycemia and posing serious health concerns for patients. Such inaccuracies may reduce user confidence in the devices and negatively impact treatment outcomes. Additionally, increasing instances of product recalls due to safety or performance issues can further challenge market growth by affecting brand reputation, regulatory scrutiny, and overall consumer trust. These factors act as significant restraints in the diabetes care devices market.

Diabetes Care Devices Market Segment Analysis

Diabetes Care Devices Market Product Type (Blood Glucose Monitoring Devices {Wearable and Non Wearable}, Insulin Delivery Devices {Insulin Syringes, Insulin Pens, Insulin Pumps, and Others} and Integrated Systems), Monitoring (Self-Monitoring and Continous Monitoring), Patient Type (Type 1, Type 2, and Gestational Diabetes), End-Users (Hospitals & Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Diabetes Care Devices Market Regional Analysis

North America Diabetes Care Devices Market Trends

North America is poised to secure the largest share of 41% in the global diabetes care devices market in 2025, due to the high prevalence of diabetes, strong healthcare infrastructure, and widespread adoption of advanced technologies such as continuous glucose monitoring (CGM) systems and insulin pumps. The region also benefits from favorable reimbursement policies, high healthcare expenditure, and strong presence of leading market players, which further support innovation and rapid product adoption. Additionally, increasing awareness about early diagnosis and effective disease management continues to drive demand for diabetes care devices in the region.

According to data provided by the Centre for Disease Control and Prevention (2026), around 40.1 million people were living with diagnosed or undiagnosed diabetes in the United States. In which 29.1 million people were living with diagnosed diabetes, including 28.8 million adults aged >=18 years. Blood glucose monitoring systems and insulin delivery devices are essential tools for managing diabetes, helping individuals regularly check and maintain their blood sugar levels. These systems, including finger-stick glucometers and continuous glucose monitors, which enable users to track glucose fluctuations throughout the day. This information allows for timely adjustments in diet, physical activity, and medication to maintain optimal blood sugar levels, prevent complications, and manage diabetes effectively.

Additionally, the increasing number of product development activities in the region by the regulatory bodies is further going to accelerate the growth of the blood glucose monitoring systems market. For instance, in August 2024, Medtronic plc, a global leader in healthcare technology, announced the U.S. Food and Drug Administration (FDA) approved its Simplera(TM) continuous glucose monitor (CGM). This approval marked the launch of the company's first disposable, all-in-one CGM, which was half the size of previous Medtronic CGMs.

In addition to this in June 2024, Prevounce Health, a leading provider of remote care management software, devices, and services, announced the launch of its first remote blood glucose monitoring device, the Pylo GL1-LTE. The blood glucose meter was clinically validated and connected to multiple cellular networks to ensure reliable data transmission throughout the US.

Thus, the factors mentioned above are expected to boost the overall market of diabetes care devices across the region.

Europe Diabetes Care Devices Market Trends

Europe is increasingly poised to play a leading role in the overall diabetes care devices market due to the rising prevalence of diabetes, strong healthcare infrastructure, and supportive government initiatives focused on chronic disease management. The region benefits from favorable reimbursement policies, growing adoption of advanced technologies such as continuous glucose monitoring (CGM) systems and insulin pumps, and increasing awareness about early diagnosis and preventive care. Additionally, continuous investments in research and innovation by key market players further support market growth across European countries.

According to the International Diabetes Federation (2024), approximately 65.6 million people in Europe were living with diabetes in 2024, with that number projected to increase to 72.4 million by 2050. This demographic shift has created a pressing need for effective and accessible diabetes management tools. In response, European countries are actively promoting early diagnosis and proactive care through awareness campaigns and favorable reimbursement policies, which have encouraged the adoption of innovative solutions like reusable pens, insulin pumps, and smart devices.

The European market is also a hub for innovation, with leading manufacturers continually launching new products and expanding the indications for existing ones. A prime example is Medtronic plc, which in July 2025 received CE Mark approval to expand the use of its MiniMed(TM) 780G system. This pivotal approval allows the automated insulin delivery (AID) system to be used by a much broader patient population, thereby escalating the overall market of diabetes drug devices.

Thus, the factors mentioned are expected to boost the market of diabetes care devices market in Europe.

Asia-Pacific Diabetes Care Devices Market Trends

The Asia-Pacific region is rapidly emerging as one of the fastest-growing and most influential markets in the global diabetes care devices industry due to the increasing prevalence of diabetes, large population base, and rising urbanization. Growing awareness about early diagnosis and improved disease management, along with expanding healthcare infrastructure, is driving greater adoption of glucose monitoring and insulin delivery devices. Additionally, improving access to healthcare services, increasing healthcare expenditure, and the growing penetration of advanced technologies are further supporting market growth across key countries in the region.

According to the International Diabetes Federation (2024), approximately 106.9 million people in South-East Asia were living with diabetes in 2024, with that number projected to increase to 184.5 million by 2050. This significant patient pool makes advanced diabetes drug delivery devices essential for managing the disease and improving patient outcomes.

Thus, the factors mentioned above are expected to boost the overall market of diabetes care devcies across the Asia-Pacific region.

Who are the major players in the diabetes care devices market?

The following are the leading companies in the diabetes care devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Becton, Dickinson and Company
  • Novo Nordisk A/S
  • Ypsomed Holding AG
  • Tandem Diabetes Care, Inc.
  • Biocon Ltd.
  • Eli Lilly and Company
  • Insulet Corporation
  • Abbott
  • Terumo Corporation
  • CeQur
  • EOFLOW CO., LTD
  • Sanofi
  • Medtronic
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services, Inc.
  • Dexcom Inc.
  • ARKRAY, Inc.
  • Senseonics
  • WaveForm Technologies, Inc.
  • B. Braun Melsungen AG
  • Others

How is the competitive landscape shaping the Diabetes Care Devices market?

The competitive landscape of the diabetes care devices market is characterized by the presence of well-established global players alongside emerging technology innovators, leading to a moderately concentrated but dynamic market environment. Major companies are increasingly focusing on product innovation, strategic partnerships, and geographic expansion to gain competitive advantage, resulting in the frequent launch of advanced continuous glucose monitoring (CGM) systems, smart insulin delivery devices, and connected digital solutions. Competitive strategies such as mergers and acquisitions, collaborations with technology firms, and investments in research and development are intensifying as players strive to differentiate their offerings and capture larger market share. While a few key players hold significant influence due to strong brand recognition, extensive distribution networks, and robust patent portfolios, smaller specialized firms are also shaping the market by introducing niche and next-generation wearable technologies. This combination of established dominance and emerging competition is driving technological advancements, improving product quality, and expanding access to diabetes care devices globally.

Recent Developmental Activities in the Diabetes Care Devices Market

  • In August 2025, Signos launched the Signos Glucose Monitoring System, the first FDA-cleared, over-the-counter glucose monitoring system designed for weight management. The system integrates the Stelo by Dexcom glucose biosensor with an AI-powered platform, providing personalized, real-time insights into how food, activity, stress, and sleep impact metabolic health.
  • In July 2025, Medtronic plc. announced that it had received CE Mark in Europe to expand indications of the MiniMed(TM) 780G system for individuals aged 2 years and older, during pregnancy, and for those with type 2 insulin-requiring diabetes.
  • In May 2025, GO-Pen ApS received FDA 510(k) clearance for the GO-PEN(R), a user-filled insulin pen compatible with standard insulin vials, providing an affordable alternative to traditional disposable pens.
  • In April 2025, Dexcom received FDA clearance for the G7 15-Day sensor, which boasts extended wear time and enhanced accuracy for diabetes management.

Diabetes Care Devices Market Segmentation

  • Diabetes Care Devices by Product Type Exposure
  • Blood Glucose Monitoring Devices
  • Wearable
  • Non Wearable
  • Insulin Delivery Devices
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Others
  • Integrated Systems
  • Diabetes Care Devices Monitoring Exposure
  • Self-Monitoring
  • Continous Monitoring
  • Diabetes Care Devices Patient Type Exposure
  • Type 1
  • Type 2
  • Gestational Diabetes
  • Diabetes Care Devices End-Users Exposure
  • Hospitals & Clinics
  • Homecare Settings
  • Others
  • Diabetes Care Devices Geography Exposure
  • North America Diabetes Care Devices Market
  • United States Diabetes Care Devices Market
  • Canada Diabetes Care Devices Market
  • Mexico Diabetes Care Devices Market
  • Europe Diabetes Care Devices Market
  • United Kingdom Diabetes Care Devices Market
  • Germany Diabetes Care Devices Market
  • France Diabetes Care Devices Market
  • Italy Diabetes Care Devices Market
  • Spain Diabetes Care Devices Market
  • Rest of Europe Diabetes Care Devices Market
  • Asia-Pacific Diabetes Care Devices Market
  • China Diabetes Care Devices Market
  • Japan Diabetes Care Devices Market
  • India Diabetes Care Devices Market
  • Australia Diabetes Care Devices Market
  • South Korea Diabetes Care Devices Market
  • Rest of Asia-Pacific Diabetes Care Devices Market
  • Rest of the World Diabetes Care Devices Market
  • South America Diabetes Care Devices Market
  • Middle East Diabetes Care Devices Market
  • Africa Diabetes Care Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations in drug delivery devices are transforming treatment by enabling smarter, more personalized, and automated therapy management. Artificial intelligence is being integrated into connected insulin pumps, smart inhalers, wearable injectors, and infusion systems to analyze real-time patient data and optimize dosage adjustments. These systems use predictive analytics to forecast patient needs, reduce dosing errors, and improve adherence through reminders and behavioral tracking. AI algorithms can also detect usage patterns, identify potential complications, and provide decision-support insights to both patients and healthcare providers. Additionally, integration with mobile apps and cloud platforms allows remote monitoring, data sharing, and personalized treatment recommendations, enhancing safety, efficiency, and overall therapeutic outcomes.

U.S. Tariff Impact Analysis on Diabetes Care Devices Market:

U.S. tariffs have increasingly become an important factor influencing the economics of drug delivery and related medical device markets. Tariffs on imported medical devices and components can raise manufacturing and acquisition costs since many devices or parts are sourced through complex global supply chains; these added costs may either erode manufacturer margins or be passed on as higher prices for healthcare providers and patients. Higher import duties can also disrupt supply chains by making certain overseas suppliers less competitive, prompting companies to reassess sourcing strategies, diversify suppliers, or consider reshoring production to avoid tariff impacts. Although some recent tariff adjustments such as the U.S. reduction of tariffs on Indian medical device exports from 50% to 18% have improved cost competitiveness for products from select countries, broader tariff policies still pose cost pressures and uncertainty across the sector. Such tariff dynamics affect pricing strategies, supply availability, and long-term planning for manufacturers of drug delivery devices and other medical technologies.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Diabetes Care devices market report study

  • Market size analysis for the current diabetes care devices market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the diabetes care devices market.
  • Various opportunities available for the other competitors in the diabetes care devices market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the current diabetes care devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the diabetes care devices market growth in the future?

Frequently Asked Questions for the Diabetes Care Devices Market

1. What is the growth rate of the diabetes care devices market?

  • The diabetes care devices market is estimated to grow at a CAGR of 7.26% during the forecast period from 2026 to 2034.

2. What is the market for diabetes care devices?

  • The global diabetes care devices market is expected to increase from USD 40,781.76 million in 2025 to USD 76,404.07 million by 2034, reflecting strong and sustained growth.

3. Which region has the highest share in the diabetes care devices market?

  • North America is expected to dominate the diabetes care devices market due to the high prevalence of diabetes, strong healthcare infrastructure, and widespread adoption of advanced technologies such as continuous glucose monitoring (CGM) systems and insulin pumps. The region also benefits from favorable reimbursement policies, high healthcare expenditure, and strong presence of leading market players, which further support innovation and rapid product adoption. Additionally, increasing awareness about early diagnosis and effective disease management continues to drive demand for diabetes care devices in the region.

4. What are the drivers for the diabetes care devices market?

  • The diabetes care devices market is primarily driven by the rising global prevalence of diabetes, fueled by increasing obesity rates, sedentary lifestyles, and aging populations. Growing awareness about early diagnosis and the importance of continuous glucose monitoring is boosting the adoption of advanced devices such as CGMs, insulin pumps, and smart insulin pens. Technological advancements, including digital connectivity, AI integration, and wearable solutions, are further enhancing patient convenience and treatment accuracy. Additionally, supportive reimbursement policies, expanding healthcare infrastructure, and increasing emphasis on self-management and home-based care are contributing to sustained market growth.

5. Who are the key players operating in the diabetes care devices market?

  • Some of the key market players operating in the diabetes care devices market include Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo Corporation, CeQur, EOFLOW CO., LTD, Sanofi, Medtronic, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, and others.

Table of Contents

1. Diabetes Care Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Diabetes Care Devices Market Executive Summary

  • 2.1 Market at Glance

3. Diabetes Care Devices Market Key Factors Analysis

  • 3.1 Diabetes Care Devices Market Drivers
    • 3.1.1 Increasing prevalence of diabetes and associated risk factors leading to a surge in Diabetes Care Devices
    • 3.1.2 Rising patient awareness and self management trends is escalating the market of Diabetes Care Devices
    • 3.1.3 Increase in product development activities among the key market players
  • 3.2 Diabetes Care Devices Market Restraints and Challenges
    • 3.2.1 False readings or technical errors can lead to incorrect insulin dosing, associated with hypoglycemia or hyperglycemia
    • 3.2.2 Increase number product recalls
  • 3.3 Diabetes Care Devices Market Opportunity
    • 3.3.1 Integration fo artificial intelligence and machine learning

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Diabetes Care Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Diabetes Care Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Blood Glucose Monitoring Devices
      • 7.1.1.1 Wearable
      • 7.1.1.2 Non Wearable
    • 7.1.2 Insulin Delivery Devices
      • 7.1.2.1 Insulin Syringes
      • 7.1.2.2 Insulin Pens
      • 7.1.2.3 Insulin Pumps
      • 7.1.2.4 Others
    • 7.1.3 Integrated Systems
  • 7.2 By Monitoring
    • 7.2.1 Self-monitoring
    • 7.2.2 Continous Monitoring
  • 7.3 By Patient Type
    • 7.3.1 Type 1
    • 7.3.2 Type 2
    • 7.3.3 Gestational Diabetes
  • 7.4 By End-Users
    • 7.4.1 Hospitals & Clinics
    • 7.4.2 Homecare Settings
    • 7.4.3 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.1.2 Canada Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.1.3 Mexico Diabetes Care Devices Market Size in USD million (2023-2034)
    • 7.5.2 Europe
      • 7.5.2.1 France Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.2.2 Germany Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.2.3 United Kingdom Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.2.4 Italy Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.2.5 Spain Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.2.6 Rest of Europe Diabetes Care Devices Market Size in USD million (2023-2034)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.3.2 Japan Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.3.3 India Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.3.4 Australia Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.3.5 South Korea Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.3.6 Rest of Asia-Pacific Diabetes Care Devices Market Size in USD million (2023-2034)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 Middle East Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.4.2 Africa Diabetes Care Devices Market Size in USD million (2023-2034)
      • 7.5.4.3 South America Diabetes Care Devices Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Diabetes Care Devices Market Company and Product Profiles

  • 10.1 Becton, Dickinson and Company
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Novo Nordisk A/S
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Ypsomed Holding AG
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Tandem Diabetes Care, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Biocon Ltd.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Eli Lilly and Company
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Insulet Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Abbott
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Terumo Corporation
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 CeQur
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 EOFLOW CO., LTD
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 Sanofi
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Medtronic
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 F. Hoffmann-La Roche Ltd.
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Johnson & Johnson Services, Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Dexcom Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 ARKRAY, Inc.
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Senseonics
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 WaveForm Technologies, Inc.
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 B. Braun Melsungen AG
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Diabetes Care Devices Market in Global (2023-2034)
  • Table 2: Diabetes Care Devices Market in Global by Product Type (2023-2034)
  • Table 3: Diabetes Care Devices Market in Global by Monitoring (2023-2034)
  • Table 4: Diabetes Care Devices Market in Global by Patient Type (2023-2034)
  • Table 5: Diabetes Care Devices Market in Global by End-Users (2023-2034)
  • Table 6: Diabetes Care Devices Market in Global by Geography (2023-2034)
  • Table 7: Diabetes Care Devices Market in North America (2023-2034)
  • Table 8: Diabetes Care Devices Market in the United States (2023-2034)
  • Table 9: Diabetes Care Devices Market in Canada (2023-2034)
  • Table 10: Diabetes Care Devices Market in Mexico (2023-2034)
  • Table 11: Diabetes Care Devices Market in Europe (2023-2034)
  • Table 12: Diabetes Care Devices Market in France (2023-2034)
  • Table 13: Diabetes Care Devices Market in Germany (2023-2034)
  • Table 14: Diabetes Care Devices Market in United Kingdom (2023-2034)
  • Table 15: Diabetes Care Devices Market in Italy (2023-2034)
  • Table 16: Diabetes Care Devices Market in Spain (2023-2034)
  • Table 17: Diabetes Care Devices Market in the Rest of Europe (2023-2034)
  • Table 18: Diabetes Care Devices Market in Asia-Pacific (2023-2034)
  • Table 19: Diabetes Care Devices Market in China (2023-2034)
  • Table 20: Diabetes Care Devices Market in Japan (2023-2034)
  • Table 21: Diabetes Care Devices Market in India (2023-2034)
  • Table 22: Diabetes Care Devices Market in Australia (2023-2034)
  • Table 23: Diabetes Care Devices Market in South Korea (2023-2034)
  • Table 24: Diabetes Care Devices Market in Rest of Asia-Pacific (2023-2034)
  • Table 25: Diabetes Care Devices Market in the Rest of the World (2023-2034)
  • Table 26: Diabetes Care Devices Market in the Middle East (2023-2034)
  • Table 27: Diabetes Care Devices Market in Africa (2023-2034)
  • Table 28: Diabetes Care Devices Market in South America (2023-2034)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Diabetes Care Devices Market Drivers
  • Figure 2: Diabetes Care Devices Market Restraints
  • Figure 3: Diabetes Care Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in Diabetes Care Devices Market
  • Figure 5: US Tariff Impact on Diabetes Care Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Diabetes Care Devices Market in Global (2023-2034)
  • Figure 10: Diabetes Care Devices Market in Global by Product Type (2023-2034)
  • Figure 11: Diabetes Care Devices Market in Global by Monitoring (2023-2034)
  • Figure 12: Diabetes Care Devices Market in Global by Patient Type (2023-2034)
  • Figure 13: Diabetes Care Devices Market in Global by End-Users (2023-2034)
  • Figure 14: Diabetes Care Devices Market in Global by Geography (2023-2034)
  • Figure 15: Diabetes Care Devices Market in North America (2023-2034)
  • Figure 16: Diabetes Care Devices Market in the United States (2023-2034)
  • Figure 17: Diabetes Care Devices Market in Canada (2023-2034)
  • Figure 18: Diabetes Care Devices Market in Mexico (2023-2034)
  • Figure 19: Diabetes Care Devices Market in Europe (2023-2034)
  • Figure 20: Diabetes Care Devices Market in France (2023-2034)
  • Figure 21: Diabetes Care Devices Market in Germany (2023-2034)
  • Figure 22: Diabetes Care Devices Market in United Kingdom (2023-2034)
  • Figure 23: Diabetes Care Devices Market in Italy (2023-2034)
  • Figure 24: Diabetes Care Devices Market in Spain (2023-2034)
  • Figure 25: Diabetes Care Devices Market in the Rest of Europe (2023-2034)
  • Figure 26: Diabetes Care Devices Market in Asia-Pacific (2023-2034)
  • Figure 27: Diabetes Care Devices Market in China (2023-2034)
  • Figure 28: Diabetes Care Devices Market in Japan (2023-2034)
  • Figure 29: Diabetes Care Devices Market in India (2023-2034)
  • Figure 30: Diabetes Care Devices Market in Australia (2023-2034)
  • Figure 31: Diabetes Care Devices Market in South Korea (2023-2034)
  • Figure 32: Diabetes Care Devices Market in Rest of Asia-Pacific (2023-2034)
  • Figure 33: Diabetes Care Devices Market in the Rest of the World (2023-2034)
  • Figure 34: Diabetes Care Devices Market in the Middle East (2023-2034)
  • Figure 35: Diabetes Care Devices Market in Africa (2023-2034)
  • Figure 36: Diabetes Care Devices Market in South America (2023-2034)
  • Figure 37: Competitive Landscape
  • Figure 38: Startup Funding & Investment Trends